Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
BMC Neurol. 2020 Nov 10;20(1):411. doi: 10.1186/s12883-020-01985-w.
Chronic subdural hematoma (CSDH) is fundamentally treatable with about a 2-31% recurrence rate. Recently, there has been renewed interest in the association between Blood Urea Nitrogen (BUN) and intracranial lesion. Therefore, this paper attempts to show the relationship between BUN and CSDH recurrence.
A total of 653 CSDH cases with Burr-hole Irrigation (BHI) were enrolled from December 2014 to April 2019. The analyzed parameters included age, gender, comorbidities, laboratory investigations, medication use and hematoma location. The cases were divided into recurrence and non-recurrence groups while postoperative BUN concentration was further separated into quartiles (Q1 ≤ 4.0 mmol/L, 4.0 < Q2 ≤ 4.9 mmol/L, 4.9 < Q3 ≤ 6.4 mmol/L, Q4 > 6.4 mmol/L). Restricted cubic spline regressions and logistic regression models were performed to estimate the effect of BUN on CSDH recurrence.
CSDH recurrence was observed in 96 (14.7%) cases. Significant distinctions were found between recurrence and non-recurrence groups in postoperative BUN quartiles of cases (P = 0.003). After adjusting for the potential confounders, the odds ratio of recurrence was 3.069 (95%CI =1.488-6.330, p = 0.002) for the highest quartile of BUN compared with the lowest quartile. In multiple-adjusted spline regression, a high BUN level visually showed a significantly high OR value of recurrence risk.
Elevated BUN at post-operation is significantly associated with the recurrence of CSDH, and it is indicated that high levels of serum BUN after evacuation may serve as a risk factor for CSDH recurrence.
慢性硬脑膜下血肿(CSDH)的基本治疗方法是约 2-31%的复发率。最近,人们对血尿素氮(BUN)与颅内病变之间的关联重新产生了兴趣。因此,本文试图显示 BUN 与 CSDH 复发之间的关系。
从 2014 年 12 月至 2019 年 4 月,共纳入 653 例接受颅骨钻孔引流术(BHI)的 CSDH 病例。分析参数包括年龄、性别、合并症、实验室检查、药物使用和血肿位置。将病例分为复发组和非复发组,同时将术后 BUN 浓度进一步分为四分位数(Q1≤4.0mmol/L、4.0<Q2≤4.9mmol/L、4.9<Q3≤6.4mmol/L、Q4>6.4mmol/L)。采用受限立方样条回归和逻辑回归模型估计 BUN 对 CSDH 复发的影响。
96 例(14.7%)发生 CSDH 复发。复发组和非复发组术后 BUN 四分位数之间存在显著差异(P=0.003)。在调整了潜在混杂因素后,与最低四分位组相比,BUN 最高四分位组的复发比值比(OR)为 3.069(95%CI=1.488-6.330,p=0.002)。在多调整样条回归中,高 BUN 水平直观地显示出复发风险的 OR 值显著升高。
术后 BUN 升高与 CSDH 复发显著相关,提示清除术后高血清 BUN 水平可能是 CSDH 复发的一个危险因素。